Alger Associates, Inc. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:11 pm Unchanged |
2023-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Alger Associates, Inc. | 73,559 5.100% |
0 (Unchanged) |
Filing |
| 2023-09-11 8:54 pm Purchase |
2023-08-31 | 13G | Forte Biosciences, Inc. FBRX |
Alger Associates, Inc. | 73,559 5.100% |
73,559 (New Position) |
Filing |